Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04396808 · ClinicalTrials.gov registry record · NA

Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer

A NA study of Prostate Cancer, sponsored by University of Michigan Rogel Cancer Center.

Recruiting
Registry status
NA
Development phase
900
Enrollment target
8
Study locations

NCT04396808 is a NA study of Prostate Cancer that is actively recruiting participants, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 900 participants, above the 607-participant average among 735 other Prostate Cancer trials with a reported enrollment target (48% higher). The trial reports 8 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04396808, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by University of Michigan Rogel Cancer Center.

RECRUITING
Registry status
NA
Development phase
900 participants
Enrollment target
8
Study locations

Study Summary

This study seeks to determine the clinical impact of Gene Expression Classifier (GEC) testing in prostate cancer care while also developing a pragmatic approach for improved GEC clinical use and future study.

Conditions Studied

Prostate Cancer

Interventions

  • DEVICE Decipher
  • DEVICE Prolaris
  • DEVICE Oncotype Dx Genomic Prostate Score (GPS)
  • OTHER Standard of care (askMUSIC score)

Study Locations (8)

Michigan

  • University of Michigan Rogel Cancer Center - Ann Arbor
  • Henry Ford Health System - Detroit
  • Sherwood Medical Center - Detroit
  • Spectrum Health Medical Group - Grand Rapids
  • Western Michigan Urological Associates - Holland

New York

  • Montefiore Medical Center - The Bronx

North Carolina

  • University of North Carolina - Chapel Hill

Pennsylvania

  • University of Pennsylvania Perelman School of Medicine - Philadelphia

Trial Details

FieldValue
Enrollment Target 900 participants
Start Date 2020-11-05
Est. Completion 2031-04-30
Phase NA

Sponsor

University of Michigan Rogel Cancer Center

292 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04396808

The ClinicalTrials.gov registry entry for NCT04396808 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 607-participant average among 735 other Prostate Cancer trials with a reported enrollment target (48% higher). The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 4 interventions - of which Decipher is the first listed.

NCT04396808 reports 8 study locations spanning 4 distinct geographic areas - top geographies include Michigan, New York, North Carolina.

Frequently Asked Questions

What is clinical trial NCT04396808 about?

NCT04396808 is a clinical study titled "Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer". This study seeks to determine the clinical impact of Gene Expression Classifier (GEC) testing in prostate cancer care while also developing a pragmatic approach for improved GEC clinical use and future study.

What is the current status of trial NCT04396808?

This trial is currently recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2020-11-05. Estimated completion is 2031-04-30.

What conditions does trial NCT04396808 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT04396808?

The interventions under investigation include: Decipher (DEVICE), Prolaris (DEVICE), Oncotype Dx Genomic Prostate Score (GPS) (DEVICE), Standard of care (askMUSIC score) (OTHER).

Who is sponsoring clinical trial NCT04396808?

This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04396808 being conducted?

This trial has 8 study locations across Michigan, New York, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.